Morgan Stanley’s NOVONIX NVX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVX
FACM
XT
VF
SAA
Morgan Stanley's NVX Position: Q2 2026 in Review
Morgan Stanley reduced its NOVONIX (NVX) stake by 12% in Q2 2026, selling an estimated $5.89K and leaving 6,319 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6695.
Morgan Stanley first reported a position in NVX in Q1 2022 and has held it in 13 quarters since. The position peaked at $609K in Q4 2025. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.
- Morgan Stanley held 6,319 shares of NOVONIX worth $29.1K as of Q2 2026.
- Morgan Stanley sold 885 NOVONIX shares in Q2 2026, an estimated $5.89K.
- NOVONIX made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6695 holding.
- Morgan Stanley first reported a position in NOVONIX in Q1 2022 and has held it in 13 quarters since.
- Morgan Stanley's NOVONIX position peaked at $609K in Q4 2025.
- 25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.